Alphagalileo > Item Display : vimarsana.com

St. Jude Children’s Research Hospital phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of....

Related Keywords

University Of Southern California , California , United States , Taiwan , San Diego , Memorial Hospital , Elizabeth Stewart , Jacquelyn Hank , Andrew Davidoff , Michael Bishop , Wayne Furman , Sara Federico , Los Angeles , Chia Wei Hsu , Rachel Brennan , Alice Yu , Matthew Krasin , Paul Sondel , Linkou Chang Gung , Beth Mccarville , Alberto Pappo , Stephen Gillies , Brandon Triplett , Barry Shulkin , Victor Santana , Sara Helmig , Haitao Pan , Jianrong Wu , University Of California , Drug Administration , Cure Childhood Cancer Foundation , University Of Hong Kong , Jude Children Research Hospitalclinical , University Of Wisconsin , Institute Of Stem Cell , Chang Gung University , Merck Kga , Translational Cancer Research , Merck Kgaa , Serono , University Of Kentucky , Department Of Oncology , Jude Children , Research Hospitalclinical , German Based Merck , Teresa Santiago , Fariba Navid , Hospital Los Angeles , Southern California , Stem Cell , Linkou Chang Gung Memorial Hospital , Wing Leung , Kid Cancer ,